Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pituitary Neoplasms | 30 | 2024 | 1313 | 5.490 |
Why?
|
Neurosurgical Procedures | 46 | 2024 | 2056 | 5.340 |
Why?
|
Craniotomy | 30 | 2022 | 741 | 4.750 |
Why?
|
Brain Neoplasms | 50 | 2022 | 8984 | 3.830 |
Why?
|
Rhinitis | 19 | 2018 | 747 | 3.810 |
Why?
|
Sinusitis | 19 | 2018 | 992 | 3.440 |
Why?
|
Defensive Medicine | 6 | 2017 | 47 | 3.200 |
Why?
|
Neurosurgery | 12 | 2022 | 670 | 2.890 |
Why?
|
Endoscopy | 23 | 2024 | 1841 | 2.860 |
Why?
|
Paranasal Sinuses | 9 | 2019 | 265 | 2.370 |
Why?
|
Postoperative Complications | 49 | 2024 | 15680 | 2.250 |
Why?
|
Spinal Diseases | 7 | 2023 | 559 | 2.030 |
Why?
|
Venous Thromboembolism | 16 | 2022 | 1866 | 1.960 |
Why?
|
Prolactinoma | 5 | 2024 | 113 | 1.880 |
Why?
|
Adenoma | 18 | 2024 | 2148 | 1.870 |
Why?
|
Malpractice | 7 | 2023 | 556 | 1.480 |
Why?
|
Glioma | 15 | 2022 | 3420 | 1.430 |
Why?
|
Skull | 6 | 2022 | 815 | 1.310 |
Why?
|
Granular Cell Tumor | 2 | 2019 | 48 | 1.250 |
Why?
|
Craniopharyngioma | 3 | 2021 | 277 | 1.070 |
Why?
|
Microsurgery | 5 | 2022 | 791 | 1.070 |
Why?
|
Glioblastoma | 13 | 2023 | 3482 | 1.070 |
Why?
|
Nasal Cavity | 4 | 2016 | 304 | 1.040 |
Why?
|
Neuroendoscopy | 5 | 2024 | 98 | 1.010 |
Why?
|
Intracranial Aneurysm | 8 | 2019 | 1276 | 1.010 |
Why?
|
Sella Turcica | 4 | 2024 | 118 | 0.960 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 4 | 2023 | 63 | 0.940 |
Why?
|
Prolactin | 4 | 2024 | 621 | 0.940 |
Why?
|
Subarachnoid Hemorrhage, Traumatic | 1 | 2024 | 13 | 0.930 |
Why?
|
Spinal Fusion | 12 | 2021 | 1280 | 0.920 |
Why?
|
Patient Readmission | 16 | 2020 | 3327 | 0.910 |
Why?
|
Decompressive Craniectomy | 2 | 2022 | 76 | 0.910 |
Why?
|
Spinal Neoplasms | 3 | 2020 | 716 | 0.880 |
Why?
|
Nasal Obstruction | 2 | 2016 | 159 | 0.880 |
Why?
|
Quality Improvement | 19 | 2020 | 3840 | 0.870 |
Why?
|
Spine | 9 | 2023 | 1111 | 0.870 |
Why?
|
Skull Base Neoplasms | 5 | 2020 | 269 | 0.860 |
Why?
|
Antibiotic Prophylaxis | 3 | 2017 | 642 | 0.860 |
Why?
|
Humans | 247 | 2024 | 760261 | 0.850 |
Why?
|
Meningioma | 7 | 2023 | 1220 | 0.840 |
Why?
|
Olfaction Disorders | 2 | 2015 | 224 | 0.830 |
Why?
|
Insurance, Liability | 3 | 2017 | 101 | 0.820 |
Why?
|
Middle Aged | 120 | 2024 | 220175 | 0.800 |
Why?
|
Human Growth Hormone | 2 | 2017 | 638 | 0.790 |
Why?
|
Pulmonary Embolism | 6 | 2022 | 2544 | 0.790 |
Why?
|
Adult | 114 | 2024 | 219847 | 0.790 |
Why?
|
Retrospective Studies | 78 | 2024 | 80301 | 0.770 |
Why?
|
Sphenoid Bone | 7 | 2024 | 177 | 0.770 |
Why?
|
Surgical Wound Infection | 6 | 2018 | 1529 | 0.770 |
Why?
|
Female | 150 | 2024 | 391011 | 0.750 |
Why?
|
Male | 144 | 2024 | 359413 | 0.750 |
Why?
|
Hormone Replacement Therapy | 2 | 2017 | 756 | 0.750 |
Why?
|
Tumor Burden | 3 | 2024 | 1897 | 0.750 |
Why?
|
Facial Pain | 2 | 2014 | 120 | 0.720 |
Why?
|
Aged | 90 | 2024 | 168995 | 0.710 |
Why?
|
Central Nervous System Cysts | 2 | 2018 | 56 | 0.710 |
Why?
|
Reoperation | 13 | 2019 | 4292 | 0.700 |
Why?
|
Treatment Outcome | 61 | 2024 | 64947 | 0.690 |
Why?
|
Cranial Nerve Neoplasms | 2 | 2018 | 134 | 0.690 |
Why?
|
Venous Thrombosis | 4 | 2022 | 1293 | 0.690 |
Why?
|
Eccrine Glands | 1 | 2020 | 52 | 0.680 |
Why?
|
Meningeal Neoplasms | 6 | 2023 | 1248 | 0.680 |
Why?
|
Databases, Factual | 13 | 2023 | 8018 | 0.670 |
Why?
|
Neoplasm Recurrence, Local | 13 | 2024 | 9274 | 0.670 |
Why?
|
Cranial Irradiation | 2 | 2019 | 391 | 0.660 |
Why?
|
Skull Neoplasms | 1 | 2020 | 173 | 0.650 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2021 | 255 | 0.630 |
Why?
|
Cadaver | 1 | 2022 | 1345 | 0.620 |
Why?
|
Natural Orifice Endoscopic Surgery | 2 | 2019 | 119 | 0.620 |
Why?
|
Sweat Gland Neoplasms | 1 | 2020 | 117 | 0.610 |
Why?
|
Postoperative Period | 9 | 2021 | 1821 | 0.600 |
Why?
|
Endovascular Procedures | 5 | 2019 | 2135 | 0.600 |
Why?
|
Chordoma | 2 | 2018 | 346 | 0.590 |
Why?
|
Headache | 3 | 2018 | 1249 | 0.590 |
Why?
|
Aged, 80 and over | 44 | 2024 | 58947 | 0.580 |
Why?
|
Middle Cerebral Artery | 2 | 2017 | 275 | 0.580 |
Why?
|
Anticoagulants | 8 | 2024 | 4896 | 0.570 |
Why?
|
Quality of Life | 16 | 2023 | 13300 | 0.570 |
Why?
|
Chronic Disease | 18 | 2018 | 9283 | 0.570 |
Why?
|
Pituitary ACTH Hypersecretion | 2 | 2021 | 178 | 0.560 |
Why?
|
Radiosurgery | 5 | 2022 | 1343 | 0.550 |
Why?
|
Exercise Therapy | 1 | 2023 | 920 | 0.550 |
Why?
|
SEER Program | 3 | 2019 | 1532 | 0.540 |
Why?
|
Cavernous Sinus | 1 | 2017 | 123 | 0.520 |
Why?
|
Aneurysm | 1 | 2019 | 337 | 0.520 |
Why?
|
Surgical Flaps | 2 | 2022 | 1666 | 0.520 |
Why?
|
Sphenoid Sinus | 6 | 2018 | 99 | 0.520 |
Why?
|
Young Adult | 46 | 2024 | 58673 | 0.520 |
Why?
|
Valproic Acid | 1 | 2018 | 442 | 0.520 |
Why?
|
Nose | 4 | 2016 | 519 | 0.510 |
Why?
|
Radiculopathy | 2 | 2021 | 200 | 0.510 |
Why?
|
Prognosis | 26 | 2023 | 29636 | 0.510 |
Why?
|
Ependyma | 1 | 2015 | 55 | 0.510 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 238 | 0.500 |
Why?
|
Anticonvulsants | 4 | 2020 | 1881 | 0.500 |
Why?
|
Follow-Up Studies | 27 | 2023 | 39254 | 0.490 |
Why?
|
Surgery, Computer-Assisted | 2 | 2024 | 1007 | 0.490 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 2 | 2008 | 323 | 0.490 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2017 | 343 | 0.480 |
Why?
|
Frontal Sinus | 1 | 2014 | 51 | 0.470 |
Why?
|
Pituitary Diseases | 3 | 2022 | 135 | 0.470 |
Why?
|
Dopamine Agonists | 2 | 2023 | 352 | 0.470 |
Why?
|
Nose Neoplasms | 1 | 2016 | 249 | 0.460 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2018 | 321 | 0.460 |
Why?
|
Neuroma, Acoustic | 3 | 2024 | 455 | 0.450 |
Why?
|
Embolization, Therapeutic | 3 | 2018 | 1411 | 0.450 |
Why?
|
Meningitis, Bacterial | 1 | 2016 | 221 | 0.450 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2023 | 1032 | 0.450 |
Why?
|
Health Care Sector | 1 | 2015 | 196 | 0.440 |
Why?
|
Risk Factors | 39 | 2024 | 74269 | 0.440 |
Why?
|
Length of Stay | 17 | 2021 | 6472 | 0.430 |
Why?
|
Hyponatremia | 1 | 2016 | 281 | 0.430 |
Why?
|
Skull Base | 6 | 2024 | 291 | 0.430 |
Why?
|
Liability, Legal | 3 | 2023 | 210 | 0.430 |
Why?
|
Cohort Studies | 25 | 2024 | 41317 | 0.430 |
Why?
|
Meningocele | 1 | 2013 | 46 | 0.430 |
Why?
|
Neuronavigation | 1 | 2014 | 164 | 0.420 |
Why?
|
Algorithms | 6 | 2023 | 13967 | 0.420 |
Why?
|
Infusion Pumps, Implantable | 1 | 2013 | 157 | 0.410 |
Why?
|
Baclofen | 1 | 2013 | 119 | 0.410 |
Why?
|
Muscle Relaxants, Central | 1 | 2013 | 92 | 0.410 |
Why?
|
Coma | 1 | 2016 | 487 | 0.410 |
Why?
|
Carcinoma, Papillary | 1 | 2017 | 785 | 0.400 |
Why?
|
Carotid Artery, Internal | 1 | 2014 | 438 | 0.400 |
Why?
|
Rare Diseases | 1 | 2017 | 619 | 0.400 |
Why?
|
Sarcoma, Myeloid | 1 | 2012 | 51 | 0.390 |
Why?
|
Publishing | 1 | 2019 | 837 | 0.390 |
Why?
|
Stereotaxic Techniques | 1 | 2014 | 549 | 0.390 |
Why?
|
Statistics as Topic | 1 | 2017 | 2363 | 0.370 |
Why?
|
Prospective Studies | 30 | 2022 | 54263 | 0.370 |
Why?
|
Paranasal Sinus Neoplasms | 3 | 2019 | 241 | 0.370 |
Why?
|
Specialties, Surgical | 1 | 2015 | 389 | 0.360 |
Why?
|
Severity of Illness Index | 8 | 2020 | 15827 | 0.360 |
Why?
|
Survival Rate | 11 | 2020 | 12806 | 0.360 |
Why?
|
DNA Modification Methylases | 2 | 2021 | 208 | 0.350 |
Why?
|
Third Ventricle | 2 | 2021 | 74 | 0.350 |
Why?
|
Adolescent | 41 | 2024 | 87747 | 0.350 |
Why?
|
Pituitary Gland | 5 | 2023 | 637 | 0.350 |
Why?
|
United States | 30 | 2023 | 72363 | 0.350 |
Why?
|
Lumbar Vertebrae | 8 | 2021 | 1867 | 0.340 |
Why?
|
Internal Fixators | 3 | 2021 | 183 | 0.340 |
Why?
|
Diskectomy | 4 | 2021 | 209 | 0.330 |
Why?
|
Incidence | 17 | 2024 | 21378 | 0.330 |
Why?
|
Heparin | 1 | 2017 | 1655 | 0.330 |
Why?
|
Sarcoma | 1 | 2020 | 1786 | 0.330 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2020 | 10340 | 0.330 |
Why?
|
Aneurysm, Ruptured | 4 | 2019 | 460 | 0.320 |
Why?
|
DNA Repair Enzymes | 2 | 2021 | 345 | 0.320 |
Why?
|
Skin Neoplasms | 2 | 2018 | 5797 | 0.320 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2557 | 0.320 |
Why?
|
Patient-Centered Care | 2 | 2015 | 1416 | 0.310 |
Why?
|
Carcinoma | 1 | 2020 | 2334 | 0.310 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2013 | 623 | 0.300 |
Why?
|
Spinal Injuries | 2 | 2021 | 300 | 0.300 |
Why?
|
Multivariate Analysis | 9 | 2019 | 12156 | 0.300 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1470 | 0.300 |
Why?
|
Logistic Models | 15 | 2022 | 13311 | 0.300 |
Why?
|
Attitude of Health Personnel | 3 | 2017 | 3870 | 0.300 |
Why?
|
Respiratory Insufficiency | 1 | 2016 | 1228 | 0.290 |
Why?
|
Spinal Curvatures | 2 | 2019 | 67 | 0.290 |
Why?
|
Decompression, Surgical | 4 | 2020 | 604 | 0.290 |
Why?
|
Preoperative Care | 5 | 2021 | 2255 | 0.280 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2021 | 1790 | 0.280 |
Why?
|
Lymphoma | 1 | 2016 | 1899 | 0.280 |
Why?
|
Glasgow Coma Scale | 3 | 2024 | 579 | 0.280 |
Why?
|
Nasal Polyps | 2 | 2016 | 397 | 0.280 |
Why?
|
Fibromyalgia | 2 | 2008 | 398 | 0.280 |
Why?
|
Gastroesophageal Reflux | 1 | 2014 | 816 | 0.270 |
Why?
|
Central Nervous System Neoplasms | 3 | 2022 | 917 | 0.270 |
Why?
|
Kyphosis | 2 | 2021 | 237 | 0.270 |
Why?
|
Mobility Limitation | 2 | 2021 | 402 | 0.270 |
Why?
|
Brain Abscess | 2 | 2018 | 120 | 0.260 |
Why?
|
Immunotherapy | 2 | 2020 | 4637 | 0.260 |
Why?
|
Models, Neurological | 1 | 2014 | 1758 | 0.260 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 2 | 2018 | 87 | 0.260 |
Why?
|
Smell | 1 | 2008 | 259 | 0.260 |
Why?
|
Canada | 3 | 2016 | 2128 | 0.260 |
Why?
|
Oligodendroglioma | 2 | 2020 | 279 | 0.260 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2880 | 0.250 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 1200 | 0.250 |
Why?
|
Hydrocephalus | 3 | 2021 | 763 | 0.250 |
Why?
|
Tomography, X-Ray Computed | 5 | 2024 | 20484 | 0.250 |
Why?
|
Spinal Cord Diseases | 2 | 2021 | 293 | 0.250 |
Why?
|
Steroids | 2 | 2021 | 928 | 0.250 |
Why?
|
Risk | 5 | 2017 | 9629 | 0.240 |
Why?
|
Informed Consent | 3 | 2022 | 1007 | 0.240 |
Why?
|
Surgical Instruments | 2 | 2018 | 385 | 0.230 |
Why?
|
Arachnoid | 1 | 2024 | 50 | 0.230 |
Why?
|
Predictive Value of Tests | 12 | 2021 | 15273 | 0.230 |
Why?
|
Spinal Stenosis | 2 | 2021 | 262 | 0.230 |
Why?
|
Stroke | 5 | 2023 | 9945 | 0.230 |
Why?
|
Intraoperative Complications | 2 | 2024 | 1186 | 0.230 |
Why?
|
Delivery of Health Care | 3 | 2019 | 5324 | 0.230 |
Why?
|
Scoliosis | 2 | 2021 | 733 | 0.220 |
Why?
|
Cervical Vertebrae | 4 | 2021 | 978 | 0.220 |
Why?
|
Astrocytoma | 2 | 2021 | 775 | 0.220 |
Why?
|
Low Back Pain | 1 | 2012 | 979 | 0.220 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2024 | 110 | 0.210 |
Why?
|
Nervous System Diseases | 3 | 2019 | 1647 | 0.210 |
Why?
|
Survival Analysis | 5 | 2020 | 10185 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 6 | 2020 | 6545 | 0.210 |
Why?
|
Diverticulum | 1 | 2024 | 137 | 0.210 |
Why?
|
Internationality | 2 | 2018 | 1005 | 0.210 |
Why?
|
Cognition Disorders | 1 | 2017 | 3976 | 0.210 |
Why?
|
Cerebral Angiography | 2 | 2019 | 1272 | 0.210 |
Why?
|
Age Distribution | 3 | 2017 | 2893 | 0.210 |
Why?
|
Privacy | 2 | 2022 | 233 | 0.200 |
Why?
|
Ventriculostomy | 2 | 2021 | 131 | 0.200 |
Why?
|
Registries | 11 | 2019 | 8449 | 0.200 |
Why?
|
Anti-Bacterial Agents | 6 | 2018 | 7400 | 0.200 |
Why?
|
Postoperative Hemorrhage | 2 | 2017 | 422 | 0.200 |
Why?
|
Self Report | 3 | 2019 | 3707 | 0.200 |
Why?
|
Endarterectomy, Carotid | 2 | 2019 | 560 | 0.190 |
Why?
|
Neoplasms | 6 | 2020 | 22066 | 0.190 |
Why?
|
Melanoma | 2 | 2018 | 5695 | 0.190 |
Why?
|
Bone Cements | 1 | 2022 | 324 | 0.180 |
Why?
|
Body Constitution | 1 | 2021 | 273 | 0.180 |
Why?
|
Cerebral Hemorrhage, Traumatic | 1 | 2020 | 20 | 0.180 |
Why?
|
Natural Language Processing | 2 | 2020 | 1136 | 0.180 |
Why?
|
Comorbidity | 7 | 2019 | 10552 | 0.180 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2020 | 56 | 0.180 |
Why?
|
Magnetic Resonance Imaging | 10 | 2021 | 36247 | 0.170 |
Why?
|
Telemedicine | 3 | 2022 | 3005 | 0.170 |
Why?
|
Brain Mapping | 2 | 2015 | 6562 | 0.170 |
Why?
|
Tinnitus | 1 | 2022 | 194 | 0.170 |
Why?
|
Alcoholic Beverages | 1 | 2021 | 264 | 0.170 |
Why?
|
Analgesics, Opioid | 3 | 2020 | 3762 | 0.170 |
Why?
|
Bone Plates | 1 | 2022 | 465 | 0.170 |
Why?
|
Urinary Tract Infections | 2 | 2016 | 817 | 0.170 |
Why?
|
Carcinoma, Ductal | 1 | 2020 | 98 | 0.170 |
Why?
|
Research Report | 2 | 2020 | 370 | 0.170 |
Why?
|
Disease-Free Survival | 3 | 2023 | 6830 | 0.170 |
Why?
|
Odds Ratio | 6 | 2021 | 9712 | 0.170 |
Why?
|
Lordosis | 2 | 2020 | 92 | 0.170 |
Why?
|
Titanium | 1 | 2022 | 484 | 0.170 |
Why?
|
Cognition | 1 | 2017 | 6948 | 0.160 |
Why?
|
Geographic Information Systems | 1 | 2021 | 280 | 0.160 |
Why?
|
Intracranial Hemorrhages | 4 | 2017 | 844 | 0.160 |
Why?
|
Time Factors | 13 | 2019 | 40133 | 0.160 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2020 | 186 | 0.160 |
Why?
|
Morals | 1 | 2022 | 289 | 0.160 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2020 | 347 | 0.160 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2018 | 40 | 0.160 |
Why?
|
Patient Discharge | 4 | 2019 | 3475 | 0.160 |
Why?
|
Abdominal Wall | 1 | 2020 | 166 | 0.160 |
Why?
|
Brachial Plexus Neuritis | 1 | 2018 | 20 | 0.160 |
Why?
|
Somatotypes | 1 | 2018 | 41 | 0.160 |
Why?
|
Health Status Indicators | 2 | 2016 | 968 | 0.150 |
Why?
|
Hematoma, Subdural | 1 | 2019 | 126 | 0.150 |
Why?
|
Pain Measurement | 3 | 2019 | 3514 | 0.150 |
Why?
|
Research Personnel | 1 | 2023 | 584 | 0.150 |
Why?
|
Speech | 1 | 2023 | 548 | 0.150 |
Why?
|
Spondylolisthesis | 1 | 2020 | 173 | 0.150 |
Why?
|
Angiography, Digital Subtraction | 1 | 2019 | 334 | 0.150 |
Why?
|
Iodide Peroxidase | 1 | 2019 | 294 | 0.150 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2020 | 635 | 0.150 |
Why?
|
Tea | 1 | 2019 | 284 | 0.150 |
Why?
|
Chondrosarcoma | 2 | 2013 | 296 | 0.150 |
Why?
|
Hematoma, Subdural, Chronic | 1 | 2018 | 92 | 0.150 |
Why?
|
Combined Modality Therapy | 5 | 2020 | 8551 | 0.150 |
Why?
|
Brain Concussion | 2 | 2021 | 1394 | 0.140 |
Why?
|
Platelet Transfusion | 1 | 2020 | 294 | 0.140 |
Why?
|
Pain, Postoperative | 4 | 2020 | 1718 | 0.140 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2018 | 104 | 0.140 |
Why?
|
Oncolytic Viruses | 1 | 2021 | 343 | 0.140 |
Why?
|
Bone Transplantation | 1 | 2022 | 922 | 0.140 |
Why?
|
Intermittent Pneumatic Compression Devices | 1 | 2017 | 28 | 0.140 |
Why?
|
Therapies, Investigational | 1 | 2018 | 111 | 0.140 |
Why?
|
Stockings, Compression | 1 | 2017 | 37 | 0.140 |
Why?
|
Adenoma, Oxyphilic | 1 | 2018 | 148 | 0.140 |
Why?
|
Pain | 2 | 2023 | 5066 | 0.140 |
Why?
|
Receptor, Notch1 | 1 | 2020 | 495 | 0.140 |
Why?
|
Scalp | 1 | 2020 | 389 | 0.140 |
Why?
|
Tranexamic Acid | 1 | 2019 | 176 | 0.140 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 1 | 2017 | 49 | 0.140 |
Why?
|
Gonadotrophs | 1 | 2016 | 19 | 0.140 |
Why?
|
Databases, Bibliographic | 1 | 2017 | 130 | 0.140 |
Why?
|
Body Mass Index | 5 | 2021 | 12901 | 0.140 |
Why?
|
DNA Methylation | 2 | 2021 | 4374 | 0.140 |
Why?
|
Thyroid Hormones | 1 | 2019 | 403 | 0.140 |
Why?
|
Watchful Waiting | 1 | 2021 | 510 | 0.140 |
Why?
|
Triiodothyronine | 1 | 2018 | 493 | 0.130 |
Why?
|
Laminectomy | 2 | 2015 | 224 | 0.130 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 3606 | 0.130 |
Why?
|
Netherlands | 2 | 2018 | 2213 | 0.130 |
Why?
|
Antifibrinolytic Agents | 1 | 2019 | 292 | 0.130 |
Why?
|
Orthopedic Procedures | 2 | 2019 | 1262 | 0.130 |
Why?
|
Vitamin K | 1 | 2018 | 321 | 0.130 |
Why?
|
Respiratory System Agents | 1 | 2016 | 30 | 0.130 |
Why?
|
Illinois | 1 | 2016 | 118 | 0.130 |
Why?
|
Aminolevulinic Acid | 1 | 2016 | 142 | 0.130 |
Why?
|
American Civil War | 1 | 2015 | 8 | 0.130 |
Why?
|
Herpesvirus 1, Human | 1 | 2021 | 753 | 0.130 |
Why?
|
Hyperprolactinemia | 1 | 2016 | 123 | 0.130 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 493 | 0.130 |
Why?
|
Verbal Behavior | 1 | 2017 | 335 | 0.130 |
Why?
|
Oncolytic Virotherapy | 1 | 2021 | 515 | 0.130 |
Why?
|
Endocrine Surgical Procedures | 1 | 2015 | 32 | 0.130 |
Why?
|
Radiology | 2 | 2020 | 2103 | 0.130 |
Why?
|
Body Size | 1 | 2018 | 462 | 0.130 |
Why?
|
Otolaryngology | 1 | 2022 | 685 | 0.130 |
Why?
|
Psychosurgery | 1 | 2015 | 86 | 0.130 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 631 | 0.120 |
Why?
|
Remission Induction | 2 | 2021 | 2394 | 0.120 |
Why?
|
Dexamethasone | 2 | 2023 | 1928 | 0.120 |
Why?
|
Meningitis, Pneumococcal | 1 | 2015 | 43 | 0.120 |
Why?
|
Sex Distribution | 2 | 2017 | 2295 | 0.120 |
Why?
|
Postoperative Care | 2 | 2018 | 1478 | 0.120 |
Why?
|
Hearing Loss | 1 | 2022 | 780 | 0.120 |
Why?
|
Coffee | 1 | 2019 | 582 | 0.120 |
Why?
|
Spinal Fractures | 1 | 2021 | 698 | 0.120 |
Why?
|
ABO Blood-Group System | 1 | 2017 | 369 | 0.120 |
Why?
|
Texas | 1 | 2016 | 401 | 0.120 |
Why?
|
Data Mining | 1 | 2020 | 553 | 0.120 |
Why?
|
United States Food and Drug Administration | 1 | 2023 | 1675 | 0.120 |
Why?
|
Meningoencephalitis | 1 | 2015 | 83 | 0.120 |
Why?
|
Hospitals | 2 | 2020 | 3929 | 0.120 |
Why?
|
Health Priorities | 1 | 2017 | 376 | 0.120 |
Why?
|
Famous Persons | 1 | 2015 | 109 | 0.120 |
Why?
|
Thoracic Vertebrae | 2 | 2016 | 597 | 0.120 |
Why?
|
Osteomyelitis | 1 | 2018 | 407 | 0.120 |
Why?
|
Hypopituitarism | 1 | 2016 | 248 | 0.120 |
Why?
|
Income | 1 | 2023 | 1876 | 0.120 |
Why?
|
Penicillins | 1 | 2017 | 403 | 0.120 |
Why?
|
Baseball | 1 | 2015 | 95 | 0.120 |
Why?
|
Head Protective Devices | 1 | 2015 | 118 | 0.120 |
Why?
|
Cerebrum | 1 | 2015 | 132 | 0.120 |
Why?
|
Recurrence | 5 | 2022 | 8487 | 0.110 |
Why?
|
Age Factors | 7 | 2021 | 18415 | 0.110 |
Why?
|
Conflict of Interest | 1 | 2019 | 549 | 0.110 |
Why?
|
Fertility | 1 | 2018 | 772 | 0.110 |
Why?
|
Cerebral Hemorrhage | 3 | 2023 | 2660 | 0.110 |
Why?
|
Wounds, Nonpenetrating | 1 | 2020 | 796 | 0.110 |
Why?
|
Anesthetics, Intravenous | 1 | 2017 | 397 | 0.110 |
Why?
|
Spinal Cord Injuries | 1 | 2021 | 923 | 0.110 |
Why?
|
Seizures | 3 | 2021 | 2916 | 0.110 |
Why?
|
Clinical Laboratory Techniques | 1 | 2019 | 749 | 0.110 |
Why?
|
Medical Records Systems, Computerized | 1 | 2020 | 1191 | 0.110 |
Why?
|
Longevity | 1 | 2021 | 1050 | 0.110 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 12968 | 0.110 |
Why?
|
Wakefulness | 2 | 2022 | 1253 | 0.110 |
Why?
|
Vena Cava Filters | 2 | 2015 | 261 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1405 | 0.110 |
Why?
|
Serum Albumin | 1 | 2016 | 674 | 0.110 |
Why?
|
Child | 11 | 2023 | 79758 | 0.110 |
Why?
|
Hydrocortisone | 1 | 2021 | 1798 | 0.110 |
Why?
|
Risk Assessment | 7 | 2020 | 24086 | 0.100 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 319 | 0.100 |
Why?
|
Mucus | 1 | 2014 | 338 | 0.100 |
Why?
|
Extremities | 1 | 2018 | 867 | 0.100 |
Why?
|
Neurology | 2 | 2018 | 779 | 0.100 |
Why?
|
Social Behavior | 1 | 2019 | 1130 | 0.100 |
Why?
|
Photosensitizing Agents | 1 | 2016 | 616 | 0.100 |
Why?
|
Cross-Cultural Comparison | 1 | 2015 | 632 | 0.100 |
Why?
|
Cerebral Infarction | 1 | 2017 | 982 | 0.100 |
Why?
|
Acromegaly | 1 | 2015 | 306 | 0.100 |
Why?
|
Patient Education as Topic | 2 | 2019 | 2311 | 0.100 |
Why?
|
Spinal Cord Neoplasms | 1 | 2014 | 264 | 0.100 |
Why?
|
Embolism, Paradoxical | 1 | 2012 | 55 | 0.100 |
Why?
|
Decision Support Techniques | 3 | 2017 | 2002 | 0.100 |
Why?
|
Medical Informatics | 1 | 2019 | 733 | 0.100 |
Why?
|
International Classification of Diseases | 1 | 2017 | 884 | 0.100 |
Why?
|
Suction | 1 | 2013 | 263 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2022 | 4012 | 0.100 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3618 | 0.100 |
Why?
|
Polyradiculopathy | 1 | 2011 | 23 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 2 | 2015 | 4044 | 0.100 |
Why?
|
Radiotherapy | 1 | 2018 | 1505 | 0.100 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2061 | 0.090 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2014 | 485 | 0.090 |
Why?
|
Depression | 1 | 2011 | 8033 | 0.090 |
Why?
|
South Africa | 1 | 2016 | 1821 | 0.090 |
Why?
|
Insurance, Health | 2 | 2020 | 2500 | 0.090 |
Why?
|
Developing Countries | 1 | 2023 | 2880 | 0.090 |
Why?
|
Cost-Benefit Analysis | 2 | 2020 | 5507 | 0.090 |
Why?
|
Prevalence | 6 | 2023 | 15687 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2804 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2020 | 2627 | 0.090 |
Why?
|
Vision Disorders | 1 | 2017 | 1084 | 0.090 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2906 | 0.090 |
Why?
|
Troponin | 1 | 2013 | 516 | 0.090 |
Why?
|
Data Collection | 1 | 2019 | 3317 | 0.090 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12532 | 0.090 |
Why?
|
Exercise | 2 | 2023 | 5783 | 0.080 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5784 | 0.080 |
Why?
|
Causality | 1 | 2016 | 1241 | 0.080 |
Why?
|
Streptococcus pneumoniae | 1 | 2015 | 732 | 0.080 |
Why?
|
Immunotherapy, Adoptive | 1 | 2019 | 1442 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11708 | 0.080 |
Why?
|
Biopsy | 1 | 2021 | 6775 | 0.080 |
Why?
|
Spinal Cord | 1 | 2017 | 1817 | 0.080 |
Why?
|
Delirium | 1 | 2020 | 1651 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7803 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2020 | 1939 | 0.080 |
Why?
|
Posture | 1 | 2013 | 954 | 0.080 |
Why?
|
Medical Oncology | 2 | 2018 | 2321 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2016 | 1914 | 0.080 |
Why?
|
Public Health | 1 | 2022 | 2655 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2021 | 3335 | 0.080 |
Why?
|
Checklist | 1 | 2015 | 827 | 0.080 |
Why?
|
Hematoma | 3 | 2018 | 769 | 0.080 |
Why?
|
Pelvis | 1 | 2013 | 743 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1799 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2018 | 2052 | 0.080 |
Why?
|
Hospital Mortality | 3 | 2019 | 5420 | 0.080 |
Why?
|
Galactorrhea | 2 | 2018 | 22 | 0.080 |
Why?
|
Piperidines | 1 | 2017 | 1650 | 0.080 |
Why?
|
Breast Neoplasms | 3 | 2020 | 21065 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1601 | 0.080 |
Why?
|
Thrombocytopenia | 1 | 2016 | 1174 | 0.080 |
Why?
|
Fluoroscopy | 1 | 2012 | 943 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20048 | 0.070 |
Why?
|
Neural Stem Cells | 1 | 2015 | 884 | 0.070 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 593 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14656 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1819 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2282 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 3201 | 0.070 |
Why?
|
Memory | 1 | 2017 | 2179 | 0.070 |
Why?
|
Dementia | 1 | 2021 | 2638 | 0.070 |
Why?
|
Head | 1 | 2013 | 922 | 0.070 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 1521 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3333 | 0.070 |
Why?
|
Attention | 1 | 2017 | 2386 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2532 | 0.070 |
Why?
|
Cross Infection | 1 | 2015 | 1434 | 0.070 |
Why?
|
Health Care Reform | 1 | 2015 | 1245 | 0.070 |
Why?
|
Area Under Curve | 2 | 2022 | 1635 | 0.070 |
Why?
|
Pediatrics | 1 | 2021 | 3587 | 0.070 |
Why?
|
Osteoma | 1 | 2005 | 12 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2014 | 6242 | 0.060 |
Why?
|
Europe | 2 | 2023 | 3433 | 0.060 |
Why?
|
Papilloma, Inverted | 1 | 2005 | 19 | 0.060 |
Why?
|
Blood Loss, Surgical | 2 | 2020 | 657 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1870 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2135 | 0.060 |
Why?
|
Preoperative Period | 2 | 2019 | 555 | 0.060 |
Why?
|
Dura Mater | 2 | 2020 | 290 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3365 | 0.060 |
Why?
|
Receptor, erbB-2 | 3 | 2020 | 2544 | 0.060 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2005 | 58 | 0.060 |
Why?
|
Hemangiopericytoma | 1 | 2005 | 71 | 0.060 |
Why?
|
Platelet Count | 2 | 2019 | 777 | 0.060 |
Why?
|
Sex Factors | 2 | 2015 | 10530 | 0.060 |
Why?
|
Angiofibroma | 1 | 2005 | 55 | 0.060 |
Why?
|
Bone Screws | 2 | 2020 | 529 | 0.060 |
Why?
|
Disabled Persons | 1 | 2014 | 1226 | 0.060 |
Why?
|
Skin | 1 | 2018 | 4468 | 0.060 |
Why?
|
Placebo Effect | 1 | 2008 | 511 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8498 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13505 | 0.060 |
Why?
|
Pregnancy | 3 | 2021 | 29725 | 0.060 |
Why?
|
Thiophenes | 1 | 2008 | 587 | 0.060 |
Why?
|
Internet | 1 | 2016 | 3074 | 0.060 |
Why?
|
Hemorrhage | 1 | 2015 | 3604 | 0.050 |
Why?
|
Brain Injuries | 1 | 2015 | 2044 | 0.050 |
Why?
|
World Health Organization | 2 | 2020 | 1319 | 0.050 |
Why?
|
History, 20th Century | 3 | 2015 | 2777 | 0.050 |
Why?
|
History, 19th Century | 2 | 2015 | 720 | 0.050 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1287 | 0.050 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2005 | 262 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2477 | 0.050 |
Why?
|
Retreatment | 1 | 2024 | 600 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2008 | 1439 | 0.050 |
Why?
|
Paranasal Sinus Diseases | 1 | 2002 | 121 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10434 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5248 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2022 | 22041 | 0.050 |
Why?
|
Brain | 3 | 2019 | 26912 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2014 | 3737 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16543 | 0.050 |
Why?
|
Fatigue | 1 | 2008 | 1544 | 0.050 |
Why?
|
Vertigo | 1 | 2022 | 202 | 0.050 |
Why?
|
Lithuania | 1 | 2019 | 13 | 0.040 |
Why?
|
Pseudarthrosis | 1 | 2020 | 54 | 0.040 |
Why?
|
Facial Nerve | 1 | 2022 | 277 | 0.040 |
Why?
|
Lumbosacral Region | 1 | 2021 | 291 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2022 | 466 | 0.040 |
Why?
|
Dizziness | 1 | 2022 | 256 | 0.040 |
Why?
|
Child, Preschool | 5 | 2021 | 42034 | 0.040 |
Why?
|
Contraceptives, Oral | 1 | 2022 | 554 | 0.040 |
Why?
|
Gold | 1 | 2023 | 485 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7468 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 8058 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 619 | 0.040 |
Why?
|
Time | 1 | 2020 | 545 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13629 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13249 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2019 | 516 | 0.040 |
Why?
|
Partial Thromboplastin Time | 1 | 2019 | 206 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1723 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 265 | 0.040 |
Why?
|
Injury Severity Score | 1 | 2021 | 1035 | 0.040 |
Why?
|
Herpes Simplex | 1 | 2021 | 477 | 0.040 |
Why?
|
Hematocrit | 1 | 2019 | 630 | 0.040 |
Why?
|
Eustachian Tube | 1 | 2018 | 96 | 0.040 |
Why?
|
Automation | 1 | 2020 | 581 | 0.040 |
Why?
|
International Normalized Ratio | 1 | 2019 | 387 | 0.040 |
Why?
|
Hypophysectomy | 1 | 2016 | 114 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 356 | 0.030 |
Why?
|
Mortality | 2 | 2018 | 2916 | 0.030 |
Why?
|
Ownership | 1 | 2019 | 339 | 0.030 |
Why?
|
Methicillin Resistance | 1 | 2017 | 199 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2017 | 210 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2023 | 1724 | 0.030 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2018 | 346 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2016 | 223 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 612 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6797 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25928 | 0.030 |
Why?
|
Linear Models | 2 | 2017 | 5876 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2015 | 4024 | 0.030 |
Why?
|
Head Injuries, Penetrating | 1 | 2015 | 28 | 0.030 |
Why?
|
Frail Elderly | 1 | 2020 | 747 | 0.030 |
Why?
|
Hospital Charges | 1 | 2017 | 359 | 0.030 |
Why?
|
Hemangioblastoma | 1 | 2015 | 63 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2020 | 1387 | 0.030 |
Why?
|
Cutaneous Fistula | 1 | 2015 | 79 | 0.030 |
Why?
|
Amenorrhea | 1 | 2018 | 480 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2019 | 1600 | 0.030 |
Why?
|
Health Status | 2 | 2019 | 4081 | 0.030 |
Why?
|
Alberta | 1 | 2014 | 66 | 0.030 |
Why?
|
Propensity Score | 1 | 2022 | 1918 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 1 | 2016 | 724 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 966 | 0.030 |
Why?
|
South Carolina | 1 | 2014 | 100 | 0.030 |
Why?
|
Oregon | 1 | 2014 | 148 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2019 | 1122 | 0.030 |
Why?
|
Boston | 2 | 2018 | 9282 | 0.030 |
Why?
|
Epidural Abscess | 1 | 2015 | 94 | 0.030 |
Why?
|
Vancomycin | 1 | 2017 | 503 | 0.030 |
Why?
|
Perioperative Care | 1 | 2021 | 1032 | 0.030 |
Why?
|
Patient Satisfaction | 2 | 2017 | 3451 | 0.030 |
Why?
|
Menopause | 1 | 2022 | 1640 | 0.030 |
Why?
|
Longitudinal Studies | 3 | 2017 | 14482 | 0.030 |
Why?
|
Brain Stem Neoplasms | 1 | 2015 | 190 | 0.030 |
Why?
|
Twins, Monozygotic | 1 | 2015 | 469 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2020 | 1272 | 0.030 |
Why?
|
Nervous System Malformations | 1 | 2015 | 244 | 0.030 |
Why?
|
Disclosure | 1 | 2019 | 738 | 0.030 |
Why?
|
Emergencies | 1 | 2019 | 1217 | 0.030 |
Why?
|
Infant | 3 | 2021 | 36030 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2018 | 1156 | 0.030 |
Why?
|
Homicide | 1 | 2015 | 295 | 0.030 |
Why?
|
Patient Care | 1 | 2018 | 624 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2019 | 1767 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 2019 | 872 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2019 | 1328 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2018 | 1266 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2016 | 1344 | 0.020 |
Why?
|
Chicago | 1 | 2012 | 244 | 0.020 |
Why?
|
Reference Values | 1 | 2019 | 4920 | 0.020 |
Why?
|
Syndrome | 1 | 2018 | 3278 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1266 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3568 | 0.020 |
Why?
|
Aftercare | 1 | 2017 | 918 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4900 | 0.020 |
Why?
|
Urban Population | 1 | 2019 | 2021 | 0.020 |
Why?
|
Sacrum | 1 | 2013 | 281 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2019 | 2202 | 0.020 |
Why?
|
Neck | 1 | 2015 | 730 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4044 | 0.020 |
Why?
|
Cerebellar Neoplasms | 1 | 2015 | 585 | 0.020 |
Why?
|
Rabbits | 1 | 2016 | 4773 | 0.020 |
Why?
|
California | 1 | 2014 | 1416 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2016 | 2932 | 0.020 |
Why?
|
Thromboembolism | 1 | 2016 | 1016 | 0.020 |
Why?
|
Drainage | 1 | 2015 | 1161 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4891 | 0.020 |
Why?
|
Risk Adjustment | 1 | 2013 | 601 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3106 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3310 | 0.020 |
Why?
|
Wounds, Gunshot | 1 | 2015 | 581 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2567 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1462 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2698 | 0.020 |
Why?
|
Rural Population | 1 | 2019 | 2267 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2021 | 7016 | 0.020 |
Why?
|
Social Class | 1 | 2017 | 2005 | 0.020 |
Why?
|
Postural Balance | 1 | 2013 | 617 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2805 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2017 | 1405 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15740 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6310 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2494 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3758 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1822 | 0.020 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2008 | 186 | 0.020 |
Why?
|
Patient Compliance | 1 | 2017 | 2689 | 0.020 |
Why?
|
Benchmarking | 1 | 2013 | 1043 | 0.020 |
Why?
|
Medicaid | 1 | 2020 | 2811 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2014 | 1826 | 0.020 |
Why?
|
Databases as Topic | 1 | 2008 | 474 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3466 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3903 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6499 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7268 | 0.020 |
Why?
|
Overweight | 1 | 2016 | 2421 | 0.020 |
Why?
|
Anesthesia | 1 | 2015 | 1584 | 0.010 |
Why?
|
Patient Care Team | 1 | 2015 | 2510 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6210 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11141 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2016 | 3185 | 0.010 |
Why?
|
Stem Cells | 1 | 2016 | 3525 | 0.010 |
Why?
|
Recovery of Function | 1 | 2014 | 2982 | 0.010 |
Why?
|
Sphenoid Sinusitis | 1 | 2002 | 10 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4317 | 0.010 |
Why?
|
Critical Care | 1 | 2015 | 2699 | 0.010 |
Why?
|
Research Design | 1 | 2018 | 6181 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6965 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4763 | 0.010 |
Why?
|
Analgesics | 1 | 2008 | 1066 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5884 | 0.010 |
Why?
|
Electrocardiography | 1 | 2013 | 6413 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15766 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11891 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18134 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26168 | 0.010 |
Why?
|
Inflammation | 1 | 2015 | 10757 | 0.010 |
Why?
|
Animals | 2 | 2016 | 167940 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2008 | 12412 | 0.010 |
Why?
|